Naz Rahman
Stock Analyst at Maxim Group
(0.08)
# 4,880
Out of 5,184 analysts
489
Total ratings
33.1%
Success rate
-12.3%
Average return
Main Sectors:
Stocks Rated by Naz Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KZIA Kazia Therapeutics | Rated: Buy | $30 → $20 | $4.92 | +306.50% | 15 | Nov 19, 2026 | |
| SCNX Scienture Holdings | Reiterated: Buy | $6 | $2.28 | +163.40% | 7 | Nov 19, 2026 | |
| CING Cingulate | Reiterated: Buy | $8 | $4.51 | +77.38% | 29 | Nov 18, 2026 | |
| NSRX Nasus Pharma | Reiterated: Buy | $7 | $2.29 | +205.68% | 2 | Nov 18, 2026 | |
| AYTU Aytu BioPharma | Downgraded: Hold | $7 | $2.66 | +163.16% | 22 | Nov 17, 2026 | |
| XTNT Xtant Medical Holdings | Downgraded: Hold | $1.5 | $0.21 | +614.29% | 5 | Nov 17, 2026 | |
| TLPH Talphera | Reiterated: Buy | $3 | $0.7852 | +282.07% | 15 | Nov 16, 2026 | |
| ACOG Alpha Cognition | Reiterated: Buy | $12 | $9.00 | +33.33% | 5 | Nov 13, 2026 | |
| VANI Vivani Medical | Reiterated: Buy | $4 | $1.14 | +250.88% | 29 | Nov 13, 2026 | |
| PALI Palisade Bio | Reiterated: Buy | $8 | $0.8399 | +852.49% | 33 | Nov 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.28 | +509.76% | 36 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.52 | +468.18% | 36 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $19.39 | +54.72% | 18 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $575 → $620 | $515.02 | +20.38% | 36 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $24.77 | +182.60% | 41 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.12 | - | 35 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.78 | - | 1 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.31 | - | 25 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.00 → €12.00 | €3.29 | +264.30% | 7 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.56 | n/a | 15 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.28 | n/a | 24 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.0021 | n/a | 11 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.4758 | n/a | 21 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.000001 | n/a | 11 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.92 | n/a | 6 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.16 | n/a | 3 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $13.17 | n/a | 1 | Aug 12, 2021 |
Kazia Therapeutics
Nov 19, 2026
Rated: Buy
Price Target: $30 → $20
Current: $4.92
Upside: +306.50%
Scienture Holdings
Nov 19, 2026
Reiterated: Buy
Price Target: $6
Current: $2.28
Upside: +163.40%
Cingulate
Nov 18, 2026
Reiterated: Buy
Price Target: $8
Current: $4.51
Upside: +77.38%
Nasus Pharma
Nov 18, 2026
Reiterated: Buy
Price Target: $7
Current: $2.29
Upside: +205.68%
Aytu BioPharma
Nov 17, 2026
Downgraded: Hold
Price Target: $7
Current: $2.66
Upside: +163.16%
Xtant Medical Holdings
Nov 17, 2026
Downgraded: Hold
Price Target: $1.5
Current: $0.21
Upside: +614.29%
Talphera
Nov 16, 2026
Reiterated: Buy
Price Target: $3
Current: $0.7852
Upside: +282.07%
Alpha Cognition
Nov 13, 2026
Reiterated: Buy
Price Target: $12
Current: $9.00
Upside: +33.33%
Vivani Medical
Nov 13, 2026
Reiterated: Buy
Price Target: $4
Current: $1.14
Upside: +250.88%
Palisade Bio
Nov 12, 2026
Reiterated: Buy
Price Target: $8
Current: $0.8399
Upside: +852.49%
Nov 6, 2026
Reiterated: Buy
Price Target: $20
Current: $3.28
Upside: +509.76%
Nov 4, 2026
Reiterated: Buy
Price Target: $20
Current: $3.52
Upside: +468.18%
Nov 4, 2026
Reiterated: Buy
Price Target: $30
Current: $19.39
Upside: +54.72%
Nov 4, 2026
Reiterated: Buy
Price Target: $575 → $620
Current: $515.02
Upside: +20.38%
Oct 30, 2026
Reiterated: Buy
Price Target: $70
Current: $24.77
Upside: +182.60%
Sep 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.12
Upside: -
Sep 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.78
Upside: -
Aug 19, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.31
Upside: -
Jul 27, 2026
Reiterated: Buy
Price Target: €16.00 → €12.00
Current: €3.29
Upside: +264.30%
Nov 19, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.56
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.28
Upside: n/a
Dec 18, 2024
Reiterated: Buy
Price Target: n/a
Current: $0.0021
Upside: n/a
Nov 20, 2024
Reiterated: Hold
Price Target: n/a
Current: $0.4758
Upside: n/a
May 17, 2023
Reiterated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 10, 2022
Reiterated: Hold
Price Target: n/a
Current: $1.92
Upside: n/a
Jan 13, 2022
Reiterated: Hold
Price Target: n/a
Current: $3.16
Upside: n/a
Aug 12, 2021
Reiterated: Buy
Price Target: $6
Current: $13.17
Upside: n/a